These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34896016)

  • 1. Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases.
    Solana JC; Moreno J; Iborra S; Soto M; Requena JM
    Trends Parasitol; 2022 Apr; 38(4):316-334. PubMed ID: 34896016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine Development.
    Srivastava A; Garg S; Karan S; Kaushik S; Ranganathan A; Pati S; Garg LC; Singh S
    Methods Mol Biol; 2022; 2410():555-566. PubMed ID: 34914067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically attenuated malaria parasites as vaccines.
    Vaughan AM; Kappe SHI
    Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
    [No Abstract]   [Full Text] [Related]  

  • 4. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Challenge of developing anti-parasite vaccines in the tropics].
    Rogier C
    Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer Parasites: Genetically Engineered
    Goswami D; Minkah NK; Kappe SHI
    J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against malaria liver stage after vaccination with live parasites.
    Rénia L
    Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against human parasitic diseases: tools, current status and perspectives.
    Abath FG
    Expert Opin Investig Drugs; 2000 Feb; 9(2):301-10. PubMed ID: 11060678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.
    Gannavaram S; Dey R; Avishek K; Selvapandiyan A; Salotra P; Nakhasi HL
    Front Immunol; 2014; 5():241. PubMed ID: 24904589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live Vaccines Against Plasmodium Preerythrocytic Stages.
    Mac-Daniel L; Ménard R
    Methods Mol Biol; 2019; 2013():189-198. PubMed ID: 31267503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Approaches and problems in vaccine development against leishmaniasis].
    Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD
    Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
    Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
    Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole organism blood stage vaccines against malaria.
    Stanisic DI; Good MF
    Vaccine; 2015 Dec; 33(52):7469-75. PubMed ID: 26428451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
    Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
    Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against malaria with live parasites.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Expert Rev Vaccines; 2006 Aug; 5(4):473-81. PubMed ID: 16989628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
    Weiss WR; Jiang CG
    PLoS One; 2012; 7(2):e31247. PubMed ID: 22355349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites.
    Finney OC; Keitany GJ; Smithers H; Kaushansky A; Kappe S; Wang R
    Vaccine; 2014 Apr; 32(19):2135-8. PubMed ID: 24582635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.